Evidence map›Paper›PMID 39073013›Full record

ArticleCNS neuroscience & therapeutics2024

Insulin attenuates LPS-induced cognitive impairment and ferroptosis through regulation of glucose metabolism in hippocampus.

Miao Sun, Min Liu, Qingxiao Li, Siyuan Liu, Huikai Yang, Yuxiang Song, Mengyao Qu, Xiaoying Zhang, Yulong Ma, Weidong Mi

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miao SunDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Min LiuDepartment of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Qingxiao LiDepartment of Nuclear Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Siyuan LiuDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Huikai YangDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yuxiang SongDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Mengyao QuDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Xiaoying ZhangDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID 0000-0002-6637-7025
Yulong MaDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID 0000-0003-0982-9571
Weidong MiDepartment of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID 0000-0002-2404-0555

Funding

National Natural Science Foundation of China 81901097National Natural Science Foundation of China 82171180National Natural Science Foundation of China 82171464National Natural Science Foundation of China 82371469
6 · The paper itself

Abstract

aimsNeuroinflammation is a recognized contributor to cognitive disorders like Alzheimer's disease, with ferroptosis emerging as a novel mechanism underlying cognitive dysfunction associated with neuroinflammation. Insulin, pivotal in the central nervous system, holds promise for cognitive function enhancement. This study aimed to establish a cognitive impairment model through intracerebroventricular injection of lipopolysaccharide (LPS) and explore the impact of intracerebroventricular insulin injection on cognitive function in mice.

methodsWe employed diverse experimental techniques, including animal behavior testing, molecular assays, targeted metabolomics, nuclear medicine, and electron microscopy, to assess neurodegenerative changes, brain insulin resistance (IR), glucose uptake and metabolism, and ferroptosis. The model of cognitive impairment was induced via intracerebroventricular injection of LPS, followed by intracerebroventricular administration of insulin to evaluate its effects.

resultsInsulin treatment effectively mitigated LPS-induced cognitive decline and safeguarded against neuronal degeneration. Furthermore, insulin alleviated LPS-induced insulin resistance, enhanced glucose uptake in the hippocampus, and promoted the Pentose Phosphate Pathway (PPP) and nicotinamide adenine dinucleotide phosphate (NADPH) production. Additionally, insulin activated the glutathione (GSH)-glutathione peroxidase 4 (GPX4) pathway, reducing lipid peroxidation, and mitochondrial damage characteristic of LPS-induced ferroptosis in the hippocampus.

conclusionOur findings underscore the therapeutic potential of insulin in alleviating LPS-induced cognitive impairment and ferroptosis by modulating glucose metabolism. This study offers a promising avenue for future interventions targeting cognitive decline.

Indexed as

Cognitive DysfunctionFerroptosisGlucoseHippocampusInsulinLipopolysaccharidesAnimalsInsulin ResistanceMaleMiceMice, Inbred C57BLGlucoseInsulinLipopolysaccharidescognitive impairmentferroptosisinsulin resistance

Identifiers

PMID39073013
PMCPMC11284243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.